Psychedelics startups are on a long journey to consumer markets, but these 5 VCs are taking the ride
TechCrunch
MAY 4, 2022
Each of them has an investment thesis that strongly overlaps with applications of psychedelics. Besides having broad applications across a range of inflammatory disorders, it also opens up a new mechanism underlying inflammatory pathways. Burkitbayeva, Shah, and Schlidt are three of the five investors we interviewed for this deep dive.
94 
Let's personalize your content